These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Dried Blood Spot Technique for the Monitoring of Ambrisentan, Bosentan, Sildenafil, and Tadalafil in Patients with Pulmonary Arterial Hypertension. Enderle Y, Meid AD, Friedrich J, Grünig E, Wilkens H, Haefeli WE, Burhenne J. Anal Chem; 2015 Dec 15; 87(24):12112-20. PubMed ID: 26583764 [Abstract] [Full Text] [Related]
3. A Focus on Macitentan in the Treatment of Pulmonary Arterial Hypertension. Bedan M, Grimm D, Wehland M, Simonsen U, Infanger M, Krüger M. Basic Clin Pharmacol Toxicol; 2018 Aug 15; 123(2):103-113. PubMed ID: 29719121 [Abstract] [Full Text] [Related]
5. The Clinical Efficacy of Endothelin Receptor Antagonists in Patients with Pulmonary Arterial Hypertension. Maki H, Hara T, Tsuji M, Saito A, Minatsuki S, Inaba T, Amiya E, Hosoya Y, Hatano M, Morita H, Yao A, Kinugawa K, Komuro I. Int Heart J; 2020 Aug 15; 61(4):799-805. PubMed ID: 32728000 [Abstract] [Full Text] [Related]
12. Simultaneous microdetermination of bosentan, ambrisentan, sildenafil, and tadalafil in plasma using liquid chromatography/tandem mass spectrometry for pediatric patients with pulmonary arterial hypertension. Yokoyama Y, Tomatsuri M, Hayashi H, Hirai K, Ono Y, Yamada Y, Todoroki K, Toyo'oka T, Yamada H, Itoh K. J Pharm Biomed Anal; 2014 Feb 15; 89():227-32. PubMed ID: 24309556 [Abstract] [Full Text] [Related]